1
TÍTULO: Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group
AUTORES: Mohamad Mohty; Florent Malard; Manuel Abecasis; Erik Aerts; Ahmed S Alaskar; Mahmoud Aljurf; Mutlu Arat; Peter Bader; Frederic Baron; Grzegorz Basak; Ali Bazarbachi; Didier Blaise; Fabio Ciceri; Selim Corbacioglu; Jean Hugues Dalle; Fiona Dignan; Takahiro Fukuda; Anne Huynh; Jurgen Kuball; Silvy Lachance; Hillard Lazarus; Tamas Masszi; Mauricette Michallet; Arnon Nagler; Mairead NiChonghaile; Shinichiro Okamoto; Antonio Pagliuca; Christina Peters; Finn B Petersen; Paul G Richardson; Tapani Ruutu; Wael Saber; Bipin N Savani; Robert Soiffer; Jan Styczynski; Elisabeth Wallhult; Ibrahim Yakoub Agha; Rafael F Duarte; Enric Carreras; ...Mais
PUBLICAÇÃO: 2020, FONTE: BONE MARROW TRANSPLANTATION, VOLUME: 55, NÚMERO: 3
INDEXADO EM: Scopus WOS
2
TÍTULO: Insights on Multiple Myeloma Treatment Strategies
AUTORES: Maria Victoria Mateos; Heinz Ludwig; Ali Bazarbachi; Meral Beksac; Joan Blade; Mario Boccadoro; Michele Cavo; Michel Delforge; Meletios A Dimopoulos; Thierry Facon; Catarina Geraldes; Hartmut Goldschmidt; Roman Hajek; Markus Hansson; Krzysztof Jamroziak; Merav Leiba; Tames Masszi; Larisa Mendeleeva; Michael O'Dwyer; Torben Plesner; Jesus F San Miguel; Christian Straka; Niels W C J van de Donk; Kwee Yong; Samo Zver; Philippe Moreau; Pieter Sonneveld; ...Mais
PUBLICAÇÃO: 2019, FONTE: HEMASPHERE, VOLUME: 3, NÚMERO: 1
INDEXADO EM: Scopus WOS
3
TÍTULO: Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT  Full Text
AUTORES: Sebastian Giebel; Myriam Labopin; Michael Potter; Xavier Poire; Henrik Sengeloev; Gerard Socie; Anne Huynh; Boris V Afanasyev; Urs Schanz; Olle Ringden; Peter Kalhs; Dietrich W Beelen; Antonio M Campos; Tamas Masszi; Jonathan Canaani; Mohamad Mohty; Arnon Nagler;
PUBLICAÇÃO: 2018, FONTE: EUROPEAN JOURNAL OF CANCER, VOLUME: 96
INDEXADO EM: Scopus WOS
4
TÍTULO: Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma  Full Text
AUTORES: Xavier Leleu; Tamas Masszi; Nizar J Bahlis; Luisa Viterbo; Bartrum Baker; Peter Gimsing; Vladimir Maisnar; Olga Samoilova; Laura Rosinol; Christian Langer; Kevin Song; Tohru Izumi; Charles Cleeland; Deborah Berg; Huamao Mark Lin; Yanyan Y Zhu; Tomas Skacel; Philippe Moreau; Paul G Richardson;
PUBLICAÇÃO: 2018, FONTE: AMERICAN JOURNAL OF HEMATOLOGY, VOLUME: 93, NÚMERO: 8
INDEXADO EM: Scopus WOS
5
TÍTULO: Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1  Full Text
AUTORES: Maria Victoria Mateos; Tamas Masszi; Norbert Grzasko; Markus Hansson; Irwindeep Sandhu; Ludek Pour; Luisa Viterbo; Sharon R Jackson; Anne Marie Stoppa; Peter Gimsing; Mehdi Hamadani; Gabriela Borsaru; Deborah Berg; Jianchang C Lin; Alessandra Di Bacco; Helgi van de Velde; Paul G Richardson; Philippe Moreau;
PUBLICAÇÃO: 2017, FONTE: HAEMATOLOGICA, VOLUME: 102, NÚMERO: 10
INDEXADO EM: Scopus WOS
6
TÍTULO: Comparable Results of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia in First Complete Molecular Remission: An Analysis By the Acute Leukemia Working Party of the EBMT
AUTORES: Sebastian Giebel; Myriam Labopin; Michael Potter; Xavier Poire; Henrik Sengeloev; Gerard Socie; Anne Huynh; Boris V Afanasyev; Urs Schanz; Olle Ringden; Peter Kalhs; Dietrich W Beelen; Antonio M Campos; Tamas Masszi; Mohamad Mohty; Arnon Nagler;
PUBLICAÇÃO: 2016, FONTE: 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) in BLOOD, VOLUME: 128, NÚMERO: 22
INDEXADO EM: WOS
7
TÍTULO: Impact of prior therapy on efficacy and safety of oral ixazomib-lenalidomide-dexamethasone (IRd) vs placebo-Rd in patients (pts) with relapsed/refractory multiple myeloma (RRMM) in TOURMALINE-MM1.
AUTORES: Maria Victoria Mateos; Tamas Masszi; Norbert Grzasko; Markus Hansson; Irwindeep Sandhu; Ludek Pour; Luisa Viterbo; Sharon R Jackson; Anne Marie Stoppa; Peter Gimsing; Mehdi Hamadani; Gabriela Borsaru; Deborah Berg; Jianchang C Lin; Helgi Van De Velde; Paul G Richardson; Philippe Moreau;
PUBLICAÇÃO: 2016, FONTE: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 34, NÚMERO: 15
INDEXADO EM: WOS
8
TÍTULO: Efficacy and safety of ixazomib plus lenalidomidedexamethasone (IRd) vs placebo-rd in patients (pts) with relapsed/refractory multiple myeloma (RRMM) by cytogenetic risk status in the global phase III Tourmaline-MM1 study.
AUTORES: Paul G Richardson; Herve Avet Loiseau; Antonio Palumbo; Luisa Viterbo; Arnon Nagler; Peter Ganly; Dina Ben Yehuda; Jesus San Miguel; Vincent V Rajkumar; Ludek Pour; Christian Langer; Nizar J Bahlis; Andrzej Pluta; Tamas Masszi; Deborah Berg; Jianchang C Lin; Helgi Van De Velde; Dixie Lee Esseltine; Alessandra di Baccot; Philippe Moreau;
PUBLICAÇÃO: 2016, FONTE: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 34, NÚMERO: 15
INDEXADO EM: WOS
9
TÍTULO: Bortezomib, Thalidomide, and Dexamethasone (VTD) Versus VTD Plus Cyclophosphamide as Induction Therapy in Previously Untreated Multiple Myeloma Patients Eligible for HDT-ASCT: A Randomized Phase 2 Trial.
AUTORES: Heinz Ludwig; Luisa Viterbo; Richard Greil; Tamas Masszi; Ivan Spicka; Ofer Shpilberg; Roman Hajek; Anna Dmoszynska; Andrew Cakana; Christopher Enny; Huaibao B Feng; Helgi van de Velde; Jean Luc Harousseau;
PUBLICAÇÃO: 2009, FONTE: 51st Annual Meeting of the American-Society-of-Hematology in BLOOD, VOLUME: 114, NÚMERO: 22
INDEXADO EM: WOS